期刊文献+

骨硬化蛋白与骨代谢 被引量:5

Sclerostin and bone metabolism
原文传递
导出
摘要 骨硬化蛋白(sclerostin),曾称硬骨素,由SOST基因编码,是一种分泌型糖蛋白。体内研究证明,骨硬化蛋白特异性地表达于骨细胞(osteocyte)中,通过作用于成骨细胞而在骨代谢中起重要作用。骨硬化蛋白基因(SOST)的表达受应力作用、激素、氧浓度等因素的影响。拮抗骨硬化蛋白可以缓解骨质疏松的症状,这为临床治疗骨质疏松等疾病提供了新思路与新方法。本文在介绍骨硬化蛋白的表达定位与分子结构的基础上,就其参与骨代谢的最新研究进展做一综述。 Sclerostin encoded by SOST gene is a secreted glycoprotein.Sclerostin is expressed exclusively by osteocytes in vivo and plays an important role in bone metabolism by affecting osteoblast’s function.The expression of sclerostin(SOST) is influenced by mechanical stimulus,hormone,oxygen and other factors.Antagonising sclerostin can reduce the degree of osteoporosis,which would provide novel insights and methods for clinical treatment of osteoporosis.With the introduction of the location and molecular structure of sclerostin,this paper has reviewed the recent advances on sclerostin’s function in bone metabolism.
出处 《生命的化学》 CAS CSCD 北大核心 2011年第5期613-618,共6页 Chemistry of Life
基金 国家自然科学基金项目(30970706)资助
关键词 SOST基因 骨硬化蛋白 骨细胞 骨形成 Wnt/β-链蛋白(catenin) SOST gene sclerostin osteocyte bone formation Wnt/β-catenin
  • 相关文献

参考文献48

  • 1Van Hul W et al. Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am J Hum Genet, 1998, 62:391-399.
  • 2Balemans W et al. Localization of the gene for sc!erosteosis to the van Buchem Disease-gene region on chromosome 17q12-q21. Am JHum Genet, 1999, 64:1661-1669.
  • 3Balemans W et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet, 2001, 10:537-543.
  • 4Brunkow ME et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet, 2001, 68:577-589.
  • 5Balemans W et al. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene. Bone, 2005, 36:943-947.
  • 6Kim CA et al. A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin. Genet Test, 2008, 12:475-479.
  • 7Piters E et al. First missense mutation in the SOST gene causing sclerosteosis by loss of Sclerostin function. Hum Mutat, 2010, 31 : E 1526-E 1543.
  • 8Balemans Wet al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet, 2002, 39:91-97.
  • 9Staehling-Hampton K et al. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet, 2002, 110:144- 152.
  • 10Loots GG et al. Genomic deletion of a long-range bone enhancer misregulates Sclerostin in Van Buchem disease. Genome Res, 2005, 15:928-935.

同被引文献104

  • 1李毅嵩,王庆敏,陈鲁峰,曾蔚林,吴志君.补肾活血法治疗老年骨质疏松性椎体压缩性骨折42例[J].福建中医药,2013,44(1):24-25. 被引量:7
  • 2倪洁,俞一心.男性骨质疏松症与双膦酸盐类药物[J].世界临床药物,2004,25(12):730-734. 被引量:1
  • 3王婷,张金超,杨梦甦,肖培根.抗骨质疏松症的单味中药及药用植物研究进展[J].中国中药杂志,2006,31(9):718-722. 被引量:14
  • 4何铭涛,梁细妹,梁祖建,张百挡.补肾健脾活血方治疗绝经后骨质疏松症临床研究[J].山东中医杂志,2007,26(7):447-449. 被引量:13
  • 5Yamamoto M. Updates on lifestyle - related diseases and bone metabo- lism. Effects of sclerestin on bone metabolism in patients with diabetes [ J ].Clin Calcium,2014,24 ( 11 ) : 1643 - 1650.
  • 6Prez - Campo FM, Safiudo C, Delgado - Calle J, et al. A Sclerostin su- per - producer cell line derived from the human cell line SaOS - 2 : a new tool for the study of the molecular mechanisms driving sclerostin expression [ J]. Calcif Tissue Int ,2014,95 ( 2 ) : 194 - 199.
  • 7Stolina M, Dwyer D, Niu QT, et al. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin an- tibody administration to ovariectomized rats [ J ]. Bone, 2014,67 : 305 - 313.
  • 8Belkhribchia MR, Collet C, Laplanche JL, et al. Novel SOST gene muta- tion in a sclerosteosis patient from Morocco:a case report [ J ]. Eur J Med Genet ,2014,57 (4) : 133 - 137.
  • 9Al"tsi H,Cohen -Kfir E,Gurt I,et al. The sirtuinl activator SRT3025 down - regulates sclerostin and rescues ovariectumy - induced bone loss and biomechanical deterioration in female mice [ J]. Endocrinology, 2014,155 (9) :3508 -3515.
  • 10Clarke BL. Anti -sclerostin antibodies:utility in treatment of osteoporo- sis [J]. Maturitas ,2014,78(3) :199 -204.

引证文献5

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部